Janus Henderson Group’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Janus Henderson Group’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,370	Closed	-$397K	–	2616
2024 Q1	$397K	Buy	11,370 +12	+0.1%	+$438	﹤0.01%	2115
2023 Q4	$432K	Sell	11,358 -17	-0.1%	-$364	﹤0.01%	2062
2023 Q3	$209K	Buy	11,375 +15	+0.1%	+$314	﹤0.01%	2361
2023 Q2	$295K	Sell	11,360 -31	-0.3%	-$724	﹤0.01%	2258
2023 Q1	$215K	Buy	+11,391	New	+$265K	﹤0.01%	2456
2021 Q2	–	Sell	-70,839	Closed	-$1.42M	–	1723
2021 Q1	$1.42M	Buy	70,839 +17,626	+33%	+$515K	﹤0.01%	1229
2020 Q4	$1.75M	Buy	+53,213	New	+$1.42M	﹤0.01%	1139

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Janus Henderson Group's INBX Position: Q2 2024 in Review

Janus Henderson Group sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 11,370 shares — an estimated $397K sold.

Janus Henderson Group first reported a position in INBX in Q4 2020 and held it in 7 quarters. The position peaked at $1.75M in Q4 2020. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Janus Henderson Group reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Janus Henderson Group sold 11,370 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $397K.
Janus Henderson Group first reported a position in Inhibrx, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
Janus Henderson Group's Inhibrx, Inc. Common Stock position peaked at $1.75M in Q4 2020.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Janus Henderson Group's 13F filing for Q2 2024, filed 14 Aug 2024.